Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-16-010437
Filing Date
2016-02-25
Accepted
2016-02-25 16:36:47
Documents
71
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2227421z10-k.htm 10-K 1448649
2 EX-23.1 a2227421zex-23_1.htm EX-23.1 4817
3 EX-31.1 a2227421zex-31_1.htm EX-31.1 7870
4 EX-32.1 a2227421zex-32_1.htm EX-32.1 4025
11 G178130.JPG g178130.jpg GRAPHIC 44690
  Complete submission text file 0001047469-16-010437.txt   7765209

Data Files

Seq Description Document Type Size
5 EX-101.INS espr-20151231.xml EX-101.INS 1943509
6 EX-101.SCH espr-20151231.xsd EX-101.SCH 47078
7 EX-101.CAL espr-20151231_cal.xml EX-101.CAL 56859
8 EX-101.LAB espr-20151231_lab.xml EX-101.LAB 506908
9 EX-101.PRE espr-20151231_pre.xml EX-101.PRE 384034
10 EX-101.DEF espr-20151231_def.xml EX-101.DEF 197527
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35986 | Film No.: 161456447
SIC: 2834 Pharmaceutical Preparations